Even as the the first batch of H1N1 vaccine was hitting the shelves, the American Medical Association revised one CPT code and issued another specifically for use when billing for H1N1 immunizations.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — An amendment that would increase reimbursement for rural doctors passed by unanimous consent during Tuesday evening’s Senate Finance Committee markup, and a provision of the bill that would cut payments for some doctors seems doomed.
No Comments »
Filed under: General Health News
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today provided a clinical development update for Perceiva, the company’s proprietary ocular sirolimus product.
No Comments »
Filed under: Pharmacy News
Amicus Therapeutics today announced it plans to initiate a Phase 1 study of AT2220 (1-deoxynojirimycin HCl), its investigational drug in development for the treatment of Pompe Disease.
No Comments »
Filed under: Pharmacy News
ParaPRO, LLC announced today the results of two Phase III clinical studies published online this month in the journal Pediatrics (Pediatrics 2009; 124:e389-e395) which concluded that a spinosad suspension was significantly more effective in eliminating head lice (pediculosis capitis) than permethrin.
No Comments »
Filed under: Pharmacy News
Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the “Company”), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that the 043 Thorough QT (TQT) trial, which is part of the cetrorelix pamoate clinical development program in benign prostatic hyperplasia (BPH), met its primary endpoint.
No Comments »
Filed under: Pharmacy News
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has initiated dosing and commenced a second clinical trial, a Phase 1B pilot proof of concept study, in the U.S. with its anticoagulant reversing agent PMX-60056 under an Investigational New Drug application (IND) [...]
No Comments »
Filed under: Pharmacy News
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been treated in the first of two pivotal trials of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation occurring in about 50 percent of melanomas and about eight [...]
No Comments »
Filed under: Pharmacy News
LifeCycle Pharma A/S today announced positive results from a completed 12 month extension phase of the Phase 2 clinical study of LCP-Tacro tablets in stable liver transplant patients.
No Comments »
Filed under: Pharmacy News
AFRESA® (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin able to more closely replicate normal glucose suppression than currently available insulins, according to data presented at the 45th Annual Meeting of the European Association for the Study of Diabetes.
No Comments »
Filed under: Pharmacy News
